A Prospective, Multicenter, Single-Arm, Post-Market Study Using the Lutonix Drug Coated Balloon for Post-Dilatation of the Bard LifeStent Vascular Stent for Treatment of Long Lesions in Femoropopliteal Arteries
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 02 May 2017
At a glance
- Drugs Paclitaxel (Primary)
- Indications Peripheral arterial disorders
- Focus Adverse reactions; Therapeutic Use
- 26 Sep 2016 Planned End Date changed from 1 Apr 2018 to 1 Nov 2018.
- 26 Sep 2016 Planned primary completion date changed from 1 Jul 2017 to 1 Sep 2017.
- 26 Sep 2016 Status changed from recruiting to active, no longer recruiting.